Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2026)

Cytek Biosciences has reported Change in Account Payables for 7 years, with the latest figure at $390000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 4.88% year-over-year to $390000.0; the trailing twelve-month figure through Mar 2026 stood at $428000.0 (down 81.99% YoY), and the FY2025 full-year result was $448000.0, down 82.65% from the prior year.
• Change in Account Payables for Q1 2026 stood at $390000.0, up from -$1.3 million in the prior quarter.
• The five-year high for Change in Account Payables was $2.8 million in Q1 2022, with the low at -$2.0 million in Q2 2023.
• Historically, Change in Account Payables has averaged $205764.7 across 5 years, with a median of $390000.0 in 2026.
• Annual changes were most pronounced in 2022 — Change in Account Payables surged 2383.93% — and 2025, when it plunged 607.36%.
• Cytek Biosciences' Change in Account Payables stood at -$908000.0 in 2022, then slumped by 97.58% to -$1.8 million in 2023, then soared by 114.38% to $258000.0 in 2024, then sank by 607.36% to -$1.3 million in 2025, then surged by 129.79% to $390000.0 in 2026.
• The last three Change in Account Payables figures came in at $390000.0 (Q1 2026), -$1.3 million (Q4 2025), and $588000.0 (Q3 2025), per Business Quant data.